LifeMD (LFMD)
(Delayed Data from NSDQ)
$9.94 USD
-0.47 (-4.51%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $9.93 -0.01 (-0.10%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
LFMD 9.94 -0.47(-4.51%)
Will LFMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LFMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LFMD
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
Health Meets Lifestyle: How Hims & Hers Is Reshaping Everyday Wellness
LFMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside?
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth
Other News for LFMD
LifeMD (LFMD) Announces Key Leadership Changes
LifeMD appoints chief operating officer
LifeMD Names COO and Promotes Two Executives | LFMD Stock News
LifeMD names Webb Dray as Chief Operating Officer, promotes two execs
LifeMD to Report Second Quarter 2025 Financial Results on August 5 | LFMD Stock News